Global Diabetes Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025 - Product Image

Global Diabetes Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025

  • ID: 4394860
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • Eli Lilly and Company
  • Medtronic plc
  • Novo Nordisk
  • MORE
Diabetes Devices Market Growth, Future Prospects and Competitive Analysis, 2017-2025, the global diabetes devices market was valued at USD 21.3 Bn in 2016, and is expected to reach USD 29.7 Bn by 2025, expanding at a CAGR of 4.6% from 2017 - 2025.

Market Insights

With approximately 385 Mn diabetic patients and a burden of 175 Mn undiagnosed population, the burden of diabetes is significant. Lifestyle, increase in obesity prevalence, dietary changes and ageing are some of the critical factors contributing to the growing prevalence of diabetes worldwide. The global diabetes management market is majorly driven by rising disease prevalence, technological innovation, growing preference for automated disease management solutions are the prime drivers of diabetes devices market.

Growth of the global diabetes management devices market is also supported by significant investments, scope of penetration in middle- and low-income countries and increasing awareness in patient population about effective diabetes management and thereby prevention of disease related complications. On the other hand, high costs of novel diabetes management products and monitors, compliance issues, safety concerns and reimbursement issues are some of the market hindrances faced by the diabetes device manufacturers.

This report classifies the overall diabetes devices market into insulin delivery devices and glucose monitoring devices segments. The insulin delivery devices segment studies individual market for insulin pumps, insulin syringes, insulin pens and insulin inhalers. The glucose monitoring products studied in this report include test strips, lancing devices and lancets, glucose meters and continuous glucose monitors. Insulin delivery devices currently take the larger share of the overall diabetes devices market and it is anticipated that the demand for these products shall remain high through the forecast period. Additionally, continuous glucose monitors is anticipated to be the fastest growing segment in the total market, where the growth is facilitated by rapid technological innovation in this field by players such as Dexcom and prove efficiency of these devices in management of both type 1 and type 2 diabetes.

Geographically, North America and Europe are the largest regional markets for diabetes devices. High awareness, diabetes prevalence and evolved reimburse systems for novel drug delivery and monitoring systems are the prime market growth drivers in these regions. Furthermore, Asia-Pacific and Middle East and Africa are the fastest growing regions in the global market. Phenomenal rise in diabetes prevalence in countries such as India, China and Middle East countries are the major growth facilitators in these region.

The overall diabetes devices market is led by F. Hoffmann La Roche through its flagship product line Accu Chek and is followed by Animas Corporation and LifeScan with their wide product offering. Eli Lilly currently is among the top players in the diabetes delivery devices segment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • Eli Lilly and Company
  • Medtronic plc
  • Novo Nordisk
  • MORE
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Insulin Delivery Devices Market Share, 2015 & 2025 (Value %)
2.2 Glucose Monitoring Devices Market, 2015 (USD Mn)
2.3 Diabetes Devices Market Share, by Geography, 2015 (Value %)

Chapter 3 Diabetes Devices Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Market Positioning, by Key Market Players

Chapter 4 Global Insulin Delivery Devices Market Analysis, (USD Mn)
4.1 Preface
4.2 Insulin Pumps
4.3 Insulin Syringes
4.4 Insulin Pens
4.5 Insulin Inhalers

Chapter 5 Global Glucose Monitoring Devices Market Analysis, 2015-2025 (USD Mn)
5.1 Preface
5.2 Glucose Test Strips
5.3 Lancing Devices and Lancets
5.4 Glucose Meters
5.5 Continuous Glucose Monitoring

Chapter 6 Global Diabetes Devices Market, by Geography, 2015-2025 (USD Mn)
6.1 Preface
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia-Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America

Chapter 7 Company Profiles
7.1 Dexcom, Inc.
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Johnson & Johnson (LifeScan, Inc. and Animas Corporation)
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Novo Nordisk
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Abbott Laboratories
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Roche Diagnostics
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 Eli Lilly and Company
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Bayer AG
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
7.7.4 News Coverage
7.8 Ypsomed AG
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Positions/Portfolio
7.8.4 News Coverage
7.9 Medtronic plc
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Positions/Portfolio
7.9.4 News Coverage
7.10 Tandem Diabetes Care, Inc.
7.10.1 Business Description
7.10.2 Financial Health and Budget Allocation
7.10.3 Product Positions/Portfolio
7.10.4 News Coverage
7.11 Sanofi S.A.
7.11.1 Business Description
7.11.2 Financial Health and Budget Allocation
7.11.3 Product Positions/Portfolio
7.11.4 News Coverage
7.12 Terumo Corporation
7.12.1 Business Description
7.12.2 Financial Health and Budget Allocation
7.12.3 Product Positions/Portfolio
7.12.4 News Coverage
7.13 Other Notable Players

List of Figures
Fig. 1 Diabetes Devices: Market Segmentation
Fig. 2 Insulin Delivery Devices Market Share, 2015 & 20255 (Value %)
Fig. 3 Glucose Monitoring Devices Market, 2015 (USD Mn)
Fig. 4 Diabetes Devices Market Share, by Geography, 2015 (Value %)
Fig. 5 Attractive Investment Proposition, Diabetes Devices Market, 2015
Fig. 6 Competitive Analysis: Market Positioning, by Key Market Players
Fig. 7 Global Insulin Pumps Market, 2015 - 2025 (USD Mn)
Fig. 8 Global Insulin Syringes Market, 2015 - 2025 (USD Mn)
Fig. 9 Global Insulin Pens Market, 2015 - 2025 (USD Mn)
Fig. 10 Global Insulin Inhalers Market, 2015 - 2025 (USD Mn)
Fig. 11 Global Glucose Test Strips Market, 2015 - 2025 (USD Mn)
Fig. 12 Global Lancing Devices and Lancets Market, 2015 - 2025 (USD Mn)
Fig. 13 Global Glucose Meters Market, 2015 - 2025 (USD Mn)
Fig. 14 Global Continuous Glucose Monitoring Market, 2015 - 2025 (USD Mn)

List of Tables
Table 1 Global Insulin Delivery Devices Market, 2015 - 2025 (USD Mn)
Table 2 Global Glucose Monitoring Devices Market, 2015 - 2025 (USD Mn)
Table 3 Global Diabetes Devices Market, by Geography, 2015 - 2025 (USD Mn)
Table 4 North America Diabetes Devices Market, by Country, 2015 - 2025 (USD Mn)
Table 5 U.S. Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 6 Canada Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 7 Europe Diabetes Devices Market, by Country, 2015 - 2025 (USD Mn)
Table 8 U.K. Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 9 Germany Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 10 Rest of Europe Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 11 Asia-Pacific Diabetes Devices Market, by Country, 2015 - 2025 (USD Mn)
Table 12 Japan Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 13 China Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 14 Rest of Asia-Pacific Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 15 Middle East and Africa Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Table 16 Latin America Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2015 - 2025 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Dexcom, Inc.
  • Johnson & Johnson (LifeScan, Inc. and Animas Corporation)
  • Novo Nordisk
  • Abbott Laboratories
  • Roche Diagnostics
  • Eli Lilly and Company
  • Bayer AG
  • Ypsomed AG
  • Medtronic plc
  • Tandem Diabetes Care, Inc.
  • Sanofi S.A.
  • Terumo Corporation
  • Other Notable Players
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll